MartaBatusMD

PubMed

• Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint i...
  Imad Tarhoni, Connor Wakefield, Revathi Kollipara, Mary J. Fidler, Marta Batus, Philip Bonomi, Jeffrey A. Borgia> ;Journal of Immunological Methods. 2021 Jan 9
• Heart dose and coronary artery calcification in patients receiving thoracic irradiation for lung cancer.
  Anel Yakupovich, Mark A. Davison, Michael Kharouta, Julius V. Turian, Christopher W. Seder, Marta Batus, Louis Fogg, Dinesh K. Kalra, Mark Kosinski, Tuncay Taskesen, T...> ;Journal of Thoracic Disease. 2020 Oct 3
• Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy a...
  Mudit Chowdhary, Neilayan Sen, Elizabeth B Jeans, Luke Miller, Marta Batus, Steven Gitelis, Dian Wang, Ross A. Abrams> ;American Journal of Clinical Oncology. 2019 Jan 1
• The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients.
  Fidler, M. J., Fhied, C. L., Roder, J., Basu, S., Sayidine, S., Fughhi, I., Pool, M., Batus, M., Bonomi, P., Borgia, J. A.> ;BMC cancer. 2018 Mar 22
• Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cyt...
  Mary J. Fidler, Casey Frankenberger, Richard Seto, Gabriela C. Lobato, Cristina Fhied, Selina Sayidine, Sanjib Basu, Mark Pool, Reem Karmali, Marta Batus, Wen Rong Lie...> ;Oncotarget. 2017 Apr 28
• 1 citations
  Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience
  Christopher Kuo, Paul Kent, Antonio D Logan, Karen Tamulonis, Kristen L. Dalton, Marta Batus, Karen S. Fernandez, Rebecca E. Mcfall> ;Pediatric Blood & Cancer. 2017 Apr 1
• Practical and theoretical implications of weight gain in advanced non-small cell lung cancer patients
  Philip Bonomi, Marta Batus, Mary J. Fidler, Jeffrey A. Borgia> ;Annals of Translational Medicine. 2017 Mar 1
• 1 citations
  Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer.
  Benjamin A. Derman, Jason Nathaniel Macklis, M. S. Azeem, Selina Sayidine, Sanjib Basu, Marta Batus, Fatema Mohammed Esmail, Jeffrey A. Borgia, Philip Bonomi, Mary J. ...> ;BMC Cancer. 2017 Feb 16
• Survival Prediction in Ambulatory Patients With Stage III/IV Non-Small Cell Lung Cancer Using the Palliative Performance Scale, ECOG, and Lung Cancer Symptom Scale.
  Sean O'Mahony, Susan Nathan, Roozbeh Mohajer, Philip Bonomi, Marta Batus, Mary J. Fidler, Kalani Wells, Naomi Kern, Shannon Sims, Darpan Amin> ;American Journal of Hospice and Palliative Medicine. 2016 May 1
• 3 citations
  Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0–2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response
  Ellis Ziel, Gregory M. Hermann, Neilayan Sen, Philip Bonomi, Michael J. Liptay, Mary J. Fidler, Marta Batus, William H. Warren, Gary W. Chmielewski, David J. Sher> ;Journal of Thoracic Oncology. 2015 Oct 1
• Treatment of advanced squamous cell carcinoma of the lung: a review
  Benjamin A. Derman, Kathryn F. Mileham, Philip Bonomi, Marta Batus, Mary J. Fidler> ;Translational lung cancer research. 2015 Jul 7
• Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
  Virag Dandekar, Jennifer Young, Krystyna Kiel, Philip Bonomi, Mary J. Fidler, Marta Batus, David J. Sher> ;American Journal of Clinical Oncology. 2015 Jan 1
• 2 citations
  Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy
  Shalini Garg, Benjamin T. Gielda, Krystyna Kiel, Julius V. Turian, Mary J. Fidler, Marta Batus, Philip Bonomi, David J. Sher> ;Practical radiation oncology. 2013 Oct 1
• Future directions for pediatric and young adult bone sarcoma.
  Joseph Finney, Paul Kent, Marta Batus> ;Current Problems in Cancer. 2013 Jul 1
• Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions
  Marta Batus, Salman Waheed, Carl E. Ruby, Lindsay Petersen, Steven D. Bines, Howard L. Kaufman> ;American Journal of Clinical Dermatology. 2013 May 16
• 3 citations
  Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
  Sher, D. J., Gielda, B. T., Liptay, M. J., Warren, W. H., Batus, M., Fidler, M. J., Garg, S., Bonomi, P.> ;Clinical lung cancer. 2012 Dec 25
• Utility of insulin-like growth factor receptor-1 expression in gefitinib-treated patients with non-small cell lung cancer.
  Mary J. Fidler, Sanjib Basu, Lela Buckingham, Kelly Walters, Sharon Mccormack, Marta Batus, John S. Coon, Philip Bonomi> ;Anticancer Research. 2012 May 1
• PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy
  Mary J. Fidler, Larry E. Morrison, Sanjib Basu, Lela Buckingham, Kelly Kaiser Walters, Marta Batus, Kristine Jacobson, Susan Jewell, John S. Coon, Philip Bonomi> ;British Journal of Cancer. 2011 Dec 6
• Increased Bcl-2 expression is associated with Bax promoter hypermethylation in neuroendocrine carcinoma (NEC) of the lung.
  McFarland DC, Batus M, Buckingham L, Coon J, Basu S, Fidler MJ, Walters KK, Borgia JA, Bonomi PD> ;J. Clin. Oncol.. 2011-05-20
• Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC).
  Batus M, Mohajer R, Pach D, Basu S, Fidler MJ, Bonomi PD> ;J. Clin. Oncol.. 2011-05-20
• 7 citations
  Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
  Gielda, B. T., Marsh, J. C., Zusag, T. W., Faber, L. P., Liptay, M. J., Basu, S., Warren, W. H., Fidler, M. J., Batus, M., Abrams, R. A., Bonomi, P.> ;Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2011 May 3
• Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer.
  Anthony W. Kim, Marta Batus, Ronald Myint, Mary J. Fidler, Sanjib Basu, Philip Bonomi, L. Penfield Faber, Sean C. Wightman, William H. Warren, Maria McIntire, Leonidas...> ;Lung Cancer. 2011 Feb 1
• Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer.
  Batus, M., Fidler, M. J., Bonomi, P. D.> ;Expert review of anticancer therapy. 2010 Oct 15
• Neoadjuvant Treatment of Rectal Gastrointestinal Stromal Tumors with Imatinib.
  Turner, J., Batus, M., Leslie, W., Coogan, C., Saclarides, T. J.> ;The American surgeon. 2010 Aug 1
• Xanthine oxidoreductase and chemosensitivity in non-small cell lung cancer.
  Myint R, Batus M, Bonomi P, Gattuso P, Warren WH, Liptay M, Faber P, Basu S, Xu X, Kim AW> ;J. Clin. Oncol.. 2009-05-20
• Join now to see all

Lectures

• Real-world clinical burden of aggressive disease (AD) in advanced/metastatic non small cell lung cancer (aNSCLC). 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019